Bone Marrow Cell Migration to the Heart in a Chimeric Mouse Model of Acute Chagasic Disease

Total Page:16

File Type:pdf, Size:1020Kb

Bone Marrow Cell Migration to the Heart in a Chimeric Mouse Model of Acute Chagasic Disease Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 112(8): 551-560, August 2017 551 Bone marrow cell migration to the heart in a chimeric mouse model of acute chagasic disease Camila Iansen Irion, Bruno Diaz Paredes, Guilherme Visconde Brasil, Sandro Torrentes da Cunha, Luis Felipe Paula, Alysson Roncally Carvalho, Antonio Carlos Campos de Carvalho, Adriana Bastos Carvalho, Regina Coeli dos Santos Goldenberg/+ Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil BACKGROUND Chagas disease is a public health problem caused by infection with the protozoan Trypanosoma cruzi. There is currently no effective therapy for Chagas disease. Although there is some evidence for the beneficial effect of bone marrow-derived cells in chagasic disease, the mechanisms underlying their effects in the heart are unknown. Reports have suggested that bone marrow cells are recruited to the chagasic heart; however, studies using chimeric mouse models of chagasic cardiomyopathy are rare. OBJECTIVES The aim of this study was to investigate the migration of bone marrow cells to the heart after T. cruzi infection in a model of chagasic disease in chimeric mice. METHODS To obtain chimerical mice, wild-type (WT) C57BL6 mice were exposed to full body irradiation (7 Gy), causing bone marrow ablation. Then, bone marrow cells from green fluorescent protein (GFP)-transgenic mice were infused into the mice. Graft effectiveness was confirmed by flow cytometry. Experimental mice were divided into four groups: (i) infected chimeric (iChim) mice; (ii) infected WT (iWT) mice, both of which received 3 × 104 trypomastigotes of the Brazil strain; (iii) non-infected chimeric (Chim) mice; and (iv) non-infected WT mice. FINDINGS At one-month post-infection, iChim and iWT mice showed first degree atrioventricular block with decreased heart rate and treadmill exercise parameters compared to those in the non-infected groups. MAIN CONCLUSIONS iChim mice showed an increase in parasitaemia, myocarditis, and the presence of amastigote nests in the heart tissue compared to iWT mice. Flow cytometry analysis did not detect haematopoietic progenitor cells in the hearts of infected mice. Furthermore, GFP+ cardiomyocytes were not detected in the tissues of chimeric mice. Key words: Chagas disease - chimeric mice - heart - bone marrow Chagas disease (CD), caused by the protozoan Try- CD4+ and CD8+ T cells are essential for parasite control panosoma cruzi, is an important health problem in Cen- and host survival (Tarleton et al. 1996). In the chronic tral and South America (Rassi Jr et al. 2010). Reports phase, parasites are rarely found in the blood. However, from World Health Organization (WHO 2016) estimate small and progressive inflammatory foci continue to de- that 6-7 million people are infected worldwide. Although velop for years, culminating in the destruction of cardio- a decrease in incidence has been observed in endemic myocytes, formation of fibrosis, and the development of countries, CD is increasing in other places, such as the dilated cardiomyopathy (Gutierrez et al. 2009) in approx- United States of America, Canada, Japan, Australia, and imately 30% of infected individuals, which can progress Europe due to migratory movement (Rassi Jr et al. 2010). to congestive heart failure (Soares et al. 2004). At this Heart impairment is the most severe and frequent mani- stage, heart transplantation is often the only therapeutic festation of this disease. During the acute phase, infec- option. However, cell therapy has emerged as a promis- tion with T. cruzi leads to high parasitaemia and tissue ing alternative treatment. Recent advances have shown parasitism, which can result in an exacerbated immune the beneficial effects of progenitor cells from bone mar- response in the heart (Gutierrez et al. 2009), including in- row (BM) in different tissues (Epperly et al. 2003, Abedi filtration of CD4+ and CD8+ T lymphocytes and macro- et al. 2007), including the heart (Orlic et al. 2001, Yoshio- phages, with a predominance of CD8+ T cells (Machado ka et al. 2005, Goldenberg et al. 2008, Jasmin et al. 2012, et al. 2005). Depletion of lymphocytes in murine models Souza et al. 2014). In a mouse model of chronic chagasic results in high susceptibility to T. cruzi, showing that cardiomyopathy, mononuclear cells from BM decreased inflammatory infiltrates and fibrosis (Soares et al. 2004) and prevented dilatation of the right ventricle (Golden- berg et al. 2008). In an acute model, mesenchymal stem cells from BM also promoted a reduction of right ven- tricular dilatation (Jasmin et al. 2012). Although there is strong evidence for a beneficial ef- doi: 10.1590/0074-02760160526 fect of BM-derived cells in chagasic and other cardio- Financial support: CNPq, CAPES, FAPERJ, INCT, Ministério da Saúde + Corresponding author: [email protected] myopathies, the mechanisms underlying the effects of Received 7 December 2016 BM cells in the heart are still unknown. Reports have Accepted 14 March 2017 shown that BM cells are recruited to repair the heart in online | memorias.ioc.fiocruz.br 552 Bone marrow cells migrate to the heart • Camila Iansen Irion et al. a model of myocardial infarction (Orlic et al. 2001, Fa- blood (PB) samples (20 µL) collected from the tail vein zel et al. 2006). Transplantation of BM expressing green were incubated with 200 µL of erythrocyte-lysing solu- fluorescent protein (GFP) into irradiated mice has been tion (BD FACS Lysing Solution, BD Biosciences) for 15 used to screen and study BM cell participation in tissue min at room temperature, washed with PBS, centrifuged repair in different organs, including the heart (Epperly at 300 × g for 3 min, and then suspended in PBS (300 et al. 2003, Abedi et al. 2007, Fujita et al. 2007, Souza et μL) for flow cytometry analysis (BD FACSAria IIu). al. 2014). Chimeric mice have been used in myocardial Chimeric mice with greater than 70% engraftment of infarction models to show the beneficial effects of BM GFP-positive cells in PB were included in the study. CD117+ cells (Fazel et al. 2006) and granulocyte colony- Preparation of antigens (lysed parasites) - To avoid stimulating factor (G-CSF) (Fujita et al. 2007) on cardiac high mortality of irradiated mice after T. cruzi infection, tissue. However, there are few studies of CD using chi- the mice were injected with lysed parasites before in- meric mouse models (Soares & dos Santos 2009, Souza et fection. To obtain lysed parasites, a monkey fibroblast al. 2014). In this study, we investigated BM cell migration cell line (LLC-MK2) was infected with T. cruzi trypo- to the heart after T. cruzi infection in an experimental mastigotes (Brazil strain; at a 1:1 parasite:cell ratio). The model of acute CD in chimeric mice and compared para- cells were maintained in DMEM supplemented with 2% sitaemia, myocarditis, parasite nests, and cardiac func- foetal bovine serum (FBS) at 37ºC with 5% CO . From tion in infected wild-type (WT) and chimeric mice. 2 day five to eight, parasites were harvested from the MATERIALS AND METHODS culture supernatant, centrifuged (1200 × g for 15 min), resuspended in 1 mL of PBS, and counted in a Neubau- Animals - Male and female C57Bl/6 mice and transgenic 6 green fluorescent protein-expressing mice [C57Bl/6-Tg(- er chamber. A suspension containing 10 parasites/mL CAG-EGFP) C14-Y01-FM131O (GFP mice)] were donated in PBS was lysed by three freeze-thaw cycles in a wa- by Dr Masaru Okabe (Okabe et al. 1997) and housed in ter bath at 37ºC and liquid nitrogen for 5 min each. A our animal facility at the Carlos Chagas Filho Biophys- complete loss of viability was verified by the absence of ics Institute (UFRJ, Rio de Janeiro, Brazil). The facility parasite bodies via light microscopy. The lysed parasite is temperature controlled (23ºC), with a 12-12h light-dark suspension (200 µL) was injected by the intraperitoneal cycle and free access to water and standard chow. The in- (IP) route 22 days before T. cruzi inoculation. vestigation was carried out in accordance with the Guide T. cruzi infection and screening - Infected groups of for the Care and Use of Laboratory Animals [DHHS pub- mice (males and females, aged 4-5 months) were inoc- lication no. (NIH) 85-23, revised in 1996, Office of Sci- ulated by IP injection with 3 × 104 bloodstream trypo- ence and Health Reports, Bethesda, MD 20892, USA] and mastigotes of the Brazil strain. Five days post infection all animal protocols were approved by the Ethics Commit- (dpi), parasitaemia was assessed by counting the number tee on the Use of Animals in Scientific Experimentation of trypomastigotes in PB diluted in 0.85% ammonium (Health Science Centre of the Federal University of Rio de chloride buffer in a Neubauer chamber, three times a Janeiro), under protocol number 163/13. week. Data are expressed as the number of trypomastig- Generation of chimeric mice - To generate chimeric otes per millilitre of blood. Mortality was assessed daily. mice, 34 C57Bl/6 mice (weighing approximately 25 g) Experimental groups - Animals were divided into were exposed to whole body radiation (7 Gy) in a linear four groups: (i) the iChim group (n = 17) and (ii) the accelerator (VarianClinac 2100 CD) used for radiother- iWT group (n = 17), which were composed of chimeric apy, resulting in BM ablation as previously described and WT C57Bl/6 mice, respectively, that received T. cru- (Paredes et al. 2012). BM cells were harvested from zi lysate (ip) at 52 days-post irradiation (dpir) and were the femurs and tibiae of GFP transgenic mice at two infected with T. cruzi 22 days after lysate injection (74 months of age by centrifugation (1500 × g for 3 min). dpir), and age-matched non-infected controls in the (iii) To isolate mononuclear cells, Bone Marrow Cells BMCs Chim group (n = 13) and (iv) WT group (n = 14).
Recommended publications
  • The Meaning of Different Forms of Structural Myocardial Injury, Immune Response and Timing of Infarct Necrosis and Cardiac Repair
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Archivio della ricerca- Università di Roma La Sapienza Send Orders for Reprints to [email protected] 6 Current Vascular Pharmacology, 2015, 13, 6-19 The Meaning of Different Forms of Structural Myocardial Injury, Immune Response and Timing of Infarct Necrosis and Cardiac Repair Emanuela Turillazzi1*, Cristoforo Pomara1, Stefania Bello1, Margherita Neri1, Irene Riezzo1 and Vittorio Fineschi2 1Institute of Legal Medicine, Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy; 2Department of Anatomical, Histological, Forensic and Orthopaedic Sciences, Sapienza Uni- versity of Rome, Rome, Italy Abstract: Although a decline in the all-cause and cardiac mortality rates following myocardial infarction (MI) during the past 3 decades has been reported, MI is a major cause of death and disability worldwide. From a pathological point of view MI consists in a particular myocardial cell death due to prolonged ischemia. After the onset of myocardial ischemia, cell death is not immediate, but takes a finite period of time to develop. Once complete myocytes’ necrosis has occurred, a process leading to a healed infarction takes place. In fact, MI is a dynamic proc- ess that begins with the transition from reversible to irreversible ischemic injury and culminates in the replacement of dead myocardium by a fibrous scar. The pathobiological mechanisms underlying this process are very complex, involving an in- flammatory response by several pathways, and pose a major challenge to ability to improve our knowledge. An improved un- derstanding of the pathobiology of cardiac repair after MI and further studies of its underlying mechanisms provide avenues for the development of future strategies directed toward the identification of novel therapies.
    [Show full text]
  • Management of Chronic Problems
    MANAGEMENT OF CHRONIC PROBLEMS ALCOHOLIC MYOPATHY A. Chaudhuri* P.O. Behan† INTRODUCTION muscles. The clinical picture may be confused with venous Alcohol has been an integral part of man’s social history thrombophlebitis when muscle involvement is asymmetric5 since antiquity. After the art of distillation was rediscovered and, rarely, dysphagia can also occur. ARM may be associated in the Middle Ages, alchemists found, in ethanol, a cure for with signs of acute liver injury (acute alcoholic hepatitis) every illness, a tradition that still continues in this age with and congestive cardiac failure. Electromyography (EMG) the Gaelic name for whisky (usquebaugh, meaning ‘water of shows profuse fibrillations and myopathic changes similar life’). In more recent times researchers have wondered to acute polymyositis. Attacks of ARM may recur on a why the enzyme alcohol dehydrogenase, which converts number of occasions following alcoholic binges. ethanol to its major metabolite, acetaldehyde, exists in the Following its original description by Hed et al. in 1962,5 body if alcohol has no physiological role. acute alcoholic myopathy is now known to present with Though ‘alcohol’ is a generic name, in practice it usually variable severity, ranging from transient asymptomatic rises means ‘ethyl alcohol’ or ‘ethanol’ (C2H5OH). Other aliphatic in serum CK and myoglobin levels to a more fulminant alcohols include methyl alcohol (methanol) and isopropyl rhabdomyolysis, myoglobinuria and renal failure.6,7 It has alcohol, both of which are used as industrial solvents, are been recently suggested that magnetic resonance (MR) occasionally implicated in accidental human poisoning and imaging of thigh and leg muscles may be useful in the have no reported direct effect on skeletal muscles.
    [Show full text]
  • Toxicological Profile for Hydrazines. US Department Of
    TOXICOLOGICAL PROFILE FOR HYDRAZINES U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Agency for Toxic Substances and Disease Registry September 1997 HYDRAZINES ii DISCLAIMER The use of company or product name(s) is for identification only and does not imply endorsement by the Agency for Toxic Substances and Disease Registry. HYDRAZINES iii UPDATE STATEMENT Toxicological profiles are revised and republished as necessary, but no less than once every three years. For information regarding the update status of previously released profiles, contact ATSDR at: Agency for Toxic Substances and Disease Registry Division of Toxicology/Toxicology Information Branch 1600 Clifton Road NE, E-29 Atlanta, Georgia 30333 HYDRAZINES vii CONTRIBUTORS CHEMICAL MANAGER(S)/AUTHOR(S): Gangadhar Choudhary, Ph.D. ATSDR, Division of Toxicology, Atlanta, GA Hugh IIansen, Ph.D. ATSDR, Division of Toxicology, Atlanta, GA Steve Donkin, Ph.D. Sciences International, Inc., Alexandria, VA Mr. Christopher Kirman Life Systems, Inc., Cleveland, OH THE PROFILE HAS UNDERGONE THE FOLLOWING ATSDR INTERNAL REVIEWS: 1 . Green Border Review. Green Border review assures the consistency with ATSDR policy. 2 . Health Effects Review. The Health Effects Review Committee examines the health effects chapter of each profile for consistency and accuracy in interpreting health effects and classifying end points. 3. Minimal Risk Level Review. The Minimal Risk Level Workgroup considers issues relevant to substance-specific minimal risk levels (MRLs), reviews the health effects database of each profile, and makes recommendations for derivation of MRLs. HYDRAZINES ix PEER REVIEW A peer review panel was assembled for hydrazines. The panel consisted of the following members: 1. Dr.
    [Show full text]
  • January 22, 2013
    January 22, 2013 Dear Centers for Medicare & Medicaid Services, I am writing to make a formal request for a new national coverage determination (NCD) for the AlloMap gene expression test that is provided by XDx Expression Diagnostics. I am formally requesting that Medicare choose not to pay a reimbursement for this test, which is an inferior diagnostic test. I will make this case using the publically available evidence below. The AlloMap gene test falls under the benefit category: diagnostic test. The AlloMap gene expression test is designed to identify individuals in need of a heart biopsy to identify acute cellular rejection in a heart transplant population. As such, this test is useful in only a small percentage of Medicare patients. It was approved by the FDA (510(k) Number: k073482) in 2008. From the FDA file k073482, the indications for use are as follows: Indication(s) for use: AlloMap Molecular Expression Testing is an In Vitro Diagnostic Multivariate Index assay (IVDMIA) test service, performed in a single laboratory, assessing the gene expression profile of RNA isolated from peripheral blood mononuclear cells (PBMC). AlloMap Testing is intended to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection (ACR) at the time of testing in conjunction with standard clinical assessment. Indicated for use in heart transplant recipients: • 15 years of age or older • At least 2 months (≥55 days) post-transplant Traditionally, the surveillance of heart transplant recipients for acute cellular rejection (ACR) and antibody mediated rejection (humoral, AMR) has been performed through the interactions of cardiologists and pathologists.
    [Show full text]
  • Consensus Statement on Endomyocardial Biopsy
    Cardiovascular Pathology 21 (2012) 245–274 Original Article 2011 Consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology ⁎ ⁎ Ornella Leone a, , John P. Veinot b, , Annalisa Angelini c, Ulrik T. Baandrup d, Cristina Basso c, Gerald Berry e, Patrick Bruneval f, Margaret Burke g, Jagdish Butany h, Fiorella Calabrese c, Giulia d'Amati i, William D. Edwards j, John T. Fallon k, Michael C. Fishbein l, Patrick J. Gallagher m, Marc K. Halushka n, Bruce McManus o, Angela Pucci p, E. René Rodriguez q, Jeffrey E. Saffitz r, Mary N. Sheppard g, Charles Steenbergen n, James R. Stone r, Carmela Tan q, Gaetano Thiene c, Allard C. van der Wal s, Gayle L. Winters r aBologna, Italy bOttawa, Ontario, Canada cPadua, Italy dHjoerring, Denmark eStanford, CA, USA fParis, France gLondon, UK hToronto, Ontario, Canada iRome, Italy jRochester, MN, USA kNew York, NY, USA lLos Angeles, CA, USA mSouthampton, UK nBaltimore, MD, USA oVancouver, BC, Canada pPisa, Italy qCleveland, OH, USA rBoston, MA, USA sAmsterdam, The Netherlands Received 3 August 2011; received in revised form 28 September 2011; accepted 7 October 2011 Abstract The Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology have produced this position paper concerning the current role of endomyocardial biopsy (EMB) for the diagnosis of cardiac diseases and its contribution to patient management, focusing on pathological issues, with these aims: • Determining appropriate EMB use in the context of current diagnostic strategies for cardiac diseases and providing recommendations for its rational utilization ⁎ Corresponding authors. O. Leone is to be contacted at U.O.
    [Show full text]
  • Cardiac Damage After Ischemic Stroke in Diabetic State
    REVIEW published: 27 August 2021 doi: 10.3389/fimmu.2021.737170 Cerebral-Cardiac Syndrome and Diabetes: Cardiac Damage After Ischemic Stroke in Diabetic State † † Hong-Bin Lin 1 , Feng-Xian Li 1 , Jin-Yu Zhang 2, Zhi-Jian You 3, Shi-Yuan Xu 1, Wen-Bin Liang 4* and Hong-Fei Zhang 1* Edited by: 1 Department of Anesthesiology, Zhujiang Hospital of Southern Medical University, Guangzhou, China, 2 State Key Laboratory of Junlei Chang, Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China, 3 Guangxi Health Commission Key Shenzhen Institutes of Advanced Laboratory of Clinical Biotechnology, Liuzhou People’s Hospital, Liuzhou, China, 4 University of Ottawa Heart Institute and Technology, Chinese Academy of Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada Sciences (CAS), China Reviewed by: Xinchun Jin, Cerebral-cardiac syndrome (CCS) refers to cardiac dysfunction following varying brain Capital Medical University, China injuries. Ischemic stroke is strongly evidenced to induce CCS characterizing as Xia Li, arrhythmia, myocardial damage, and heart failure. CCS is attributed to be the second Fourth Military Medical University, China leading cause of death in the post-stroke stage; however, the responsible mechanisms *Correspondence: are obscure. Studies indicated the possible mechanisms including insular cortex injury, Wen-Bin Liang autonomic imbalance, catecholamine surge, immune response, and systemic [email protected] fl Hong-Fei Zhang in ammation. Of note, the characteristics of the stroke population reveal a common [email protected] comorbidity with diabetes. The close and causative correlation of diabetes and stroke †These authors have contributed directs the involvement of diabetes in CCS.
    [Show full text]
  • Small Cardiac Lesions Fibrosis of Papillary Muscles and Focal
    Small Cardiac Lesions Fibrosis of Papillary Muscles and Focal Cardiac Myocytolysis Arthur STEER, M.D.,1 Teruyuki NAKASHIMA, M.D.,2 Taketsugu KAWASHIMA, M.D.,1 Kelvin K. LEE, M.A.,3 Michael D. DANZIG, M.D.,4* Thomas L. ROBERTSON M.D.,4** and Donald S. DOCK, M.D.4 SUMMARY Three types of small cardiac lesions were described and illustrated: (1) focal type of papillary muscle fibrosis, evidently a healed infarct of the papillary muscle present in 13% of the autopsies, is a histologically characteristic lesion associated with coronary artery disease and healed myocardial infarction, (2) diffuse type of papillary muscle fibrosis, prob- ably an aging change present in almost half of the autopsies, is associated with sclerosis of the arteries in the papillary muscle, is identifiable his- tologically, and apparently is not associated with any cardiac abnormal- ity, and (3) focal cardiac myocytolysis, a unique histologic lesion, usually multifocal without predilection for any area of the heart, is associated with ischemic heart disease, death due to cancer complicated by non- bacterial thrombotic endocarditis and microthrombi in small cardiac arteries as well as with other diseases. Differentiation of the 2 types of papillary muscle fibrosis is important in the study of papillary muscle and mitral valve dysfunction. Focal cardiac myocytolysis may contribute to the fatal extension of myocardial infarcts. From the Radiation Effects Research Foundation Hiroshima and Nagasaki. A Cooperative Research Institute supported by funds from the U.S.A. National Academy of Sciences-National Research Council, Atomic Energy Commission and Environmental Protection Agency and from the Japanese National Institute of Health of the Ministry of Health and Welfare.
    [Show full text]
  • Inflammatory Heart Diseases –
    Cardiovascular Pathology – inflammatory heart diseases – Semmelweis University 2017/2018 – Autumn Semester 2nd Department of Pathology Tibor Glasz MD PhD _______ _______ _______ _______ Inflammatory cardiac diseases ____________________ _____________________ Inflammatory heart diseases - Endocarditides - parietal - valvular - Myocarditis Pancarditis - Pericarditis Endocarditides The infective endocarditides - Risk groupes: ~ rheumatic or degenerative valvular deformities ~ congenital valvular vitia ~ valvular prostheses ~ arterial long-term catheter ~ intravenous drug abusers (15% of cases, here: localisation typically tricuspidal!) - Infective agents: ~ almost always bacteria (Staphylococcus auerus, Streptococcus viridans, Gonococci, Enterobacteria; in immunodeficiency: so-called opportunistic bacteria) ~ seldom fungi (in immunodeficiency /AIDS/ and iv. drug abusers) http://images.md Congenital bicuspidy The infective endocarditides - Clinical forms: ~ acute: sudden beginning with high fever and septic crisis > despite antibiotics mortality very high ~ subacute (endocarditis subacuta infectiva/lenta): begins inconspicuously with uncharacteristic systemic symptoms (weakness, fever, weight loss) The infective endocarditides - Morphology: the same in both forms: ~ valvular vegetations along the closing lines of the valves: from small, finely granular to gross polypoid, stenosing ~ the material of the vegetations may harbour large amounts of infective agents and is highly friable > danger of embolism > formation of metastatic abscesses
    [Show full text]
  • General Characteristics of Cardiac Infarct Cardiac Infarct Comprises Three Phases: Necrosis, Reactive Exuda- Tion, and Repair
    FOCAL MYOCYTOLYSIS OF THE HEART * MONROE J. SCHLESINGER, M.D.,t and LEOPOLD REmIm, M.D. From the Pathology Laboratory, Beth Israel Hospital, and the Department of Pathology, Harvard Medical School, Boston, Mass. In this communication we wish to focus attention on a miliary lesion of the myocardium not hitherto emphasized and commonly seen in coronary heart disease. We have characterized the lesion as focal myocytolysis. Others have described it under various designations such as acute miliary infarction,l focal necrotizing myocarditis with- out interstitial infiltration,2 and sarcolytic myocardosis.3 Focal myocytolysis as it appears at the borders of cardiac infarcts was appreciated as early as I904 by Smith,4 but seemingly has since been forgotten. It has been described also in various non- coronary cardiac conditions.' 2'5-9 Focal myocytolysis of the heart has been noted in several diseases not essentially cardiac.3 12 It has been produced experimentally in a variety of animals.1318 In spite of its rather common occurrence, its morphologic and functional significance has not been appreciated generally. In speed of evolution and histologic details, focal myocytolysis is intermediate between the reversible degenerations of the myocardium and the irreversible coagulation necrosis of an infarct. The lesion is closely similar to, and probably has been confused with, some forms of infarction. Hence, it is necessary first to delineate our concept of infarction in the heart. General Characteristics of Cardiac Infarct Cardiac infarct comprises three phases: necrosis, reactive exuda- tion, and repair. By standard morphologic criteria, an infarct does not become demonstrable, grossly or histologically, for I2 to 24 hours after its clinical onset.
    [Show full text]
  • Conducting Tissue of the Heart in Kwashiorkor
    Br Heart J: first published as 10.1136/hrt.34.8.828 on 1 August 1972. Downloaded from British Heart J'ournal, I972, 34, 828-829. Conducting tissue of the heart in kwashiorkor B. A. Sims From the Department of Pathology, Queen's University of Belfast The conducting tissue of the heart was examined histologically in 7 cases of kwashiorkor. Atro- phic changes were found, and in 5 cases myocytolysis was present. No cellular reaction orfibrous repair was found in relation to the areas of myocytolysis. These findings may be associated with a disturbance of atrioventricular conduction during life, perhaps accounting for some of the unexplained sudden deaths occurring in children with kwashiorkor. There is now considerable evidence to suggest The children in the 7 cases were aged i to 3 that the heart is involved in kwashiorkor. years, showing skin changes and oedema Gopalan (I955) reported electrocardiographic characteristic of kwashiorkor in most in- abnormalities such as bradycardia, T wave stances. The commonest cause of death was changes, and a prolonged QT interval, while a respiratory infection. histologically there was atrophy of the cardiac Histological examination of the myocar- muscle fibres. A special study of the heart in dium shows the muscle fibres to be atrophic kwashiorkor was made by Smythe, Swane- but no degenerative change is evident. In the poel, and Campbell (I962) in which they conducting tissue the wasting of the fibres is analysed the electrocardiogram to find T wave more obvious. They contain vacuoles and are inversion and a prolonged QT interval. surrounded by interstitial oedema as shown Histological examination in 24 cases revealed in the Fig.
    [Show full text]
  • Dilated Cardiomyopathy
    PRIMER Dilated cardiomyopathy Heinz- Peter Schultheiss1,2*, DeLisa Fairweather3*, Alida L. P. Caforio4, Felicitas Escher1,2,5, Ray E. Hershberger6, Steven E. Lipshultz7,8,9, Peter P. Liu10, Akira Matsumori11, Andrea Mazzanti12,13, John McMurray14 and Silvia G. Priori12,13 Abstract | Dilated cardiomyopathy (DCM) is a clinical diagnosis characterized by left ventricular or biventricular dilation and impaired contraction that is not explained by abnormal loading conditions (for example, hypertension and valvular heart disease) or coronary artery disease. Mutations in several genes can cause DCM, including genes encoding structural components of the sarcomere and desmosome. Nongenetic forms of DCM can result from different aetiologies, including inflammation of the myocardium due to an infection (mostly viral); exposure to drugs, toxins or allergens; and systemic endocrine or autoimmune diseases. The heterogeneous aetiology and clinical presentation of DCM make a correct and timely diagnosis challenging. Echocardiography and other imaging techniques are required to assess ventricular dysfunction and adverse myocardial remodelling, and immunological and histological analyses of an endomyocardial biopsy sample are indicated when inflammation or infection is suspected. As DCM eventually leads to impaired contractility, standard approaches to prevent or treat heart failure are the first-line treatment for patients with DCM. Cardiac resynchronization therapy and implantable cardioverter–defibrillators may be required to prevent life-threatening
    [Show full text]
  • Patológia Srdca
    Zuzana Čierna Department of Pathology, FMCU Congenital Acquired Diseases of endocardium Diseases of myocardium Diseases of pericardium Congenital Acquired Diseases of endocardium ◦ Endocarditis ◦ Valvular diseases of the heart Diseases of myocardium Diseases of pericardium Inflammation of the endocardial layer of the heart . Rheumatic (part of rheumatic fever) . Non- rheumatic Non-infective Atypical verrucous (Liebman-Sacks) Non-bacterial thrombotic (cachektic, marantic) Infective Infective bacterial Specific types of infective (tbc, syphilitic, fungal, viral, rickettsial) Inflammation of the endocardial layer of the heart . Rheumatic (part of rheumatic fever) . Non- rheumatic Non-infective Atypical verrucous (Liebman-Sacks) Non-bacterial thrombotic (cachektic, marantic) Infective Infective bacterial Specific types of infective (tbc, syphilitic, fungal, viral, rickettsial) A systemic non-suppurative inflammatory disease after infection (upper RT) of β-haemolytic streptococcus of group A Immunologically conditioned disease, autoimmune reaction (2-3 weeks after infection) Affection of – heart, joints, CNS, skin, subcutaneous tissues „rheumatism licks the joint, but bites the whole heart“ Ernst-Charles Lasègue (French physician) Ag of Streptococcus of group A Ag of the human body Cell wall polysaccharide Cardiac valves Hyaluronate capsule Hyaluronate acid in joints Membrane antigens Sarcolemma of smooth and cardiac muscle, dermal fibroblasts, neurons of nucleus caudatus Children aged 5 – 15 years 2 – 3 weeks after
    [Show full text]